Sign in
SCHEDULE 13D

Beneficial Ownership Report

Atara Biotherapeutics, Inc. Filed Acc 0001104659-25-052422

Stakes reported in this filing

Reporting person Shares Of the class
Redmile Group, LLC 705,207 9.9%
Jeremy C. Green 705,207 9.9%
Redmile Biopharma Investments II, L.P. 406,137 5.8%
RedCo I, L.P. 347,442 5.0%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13D_X01/primary_doc.xml…